Ozone enhancement of lower airway allergic inflammation is prevented by γ-tocopherol

Free Radical Biology and Medicine

Volumn 43, Issue 8, 2007, Pages 1176-1188

  Wagner, James G ^a   Jiang, Qing ^b   Harkema, Jack R ^a   Illek, Beate ^c   Patel, Dhavalkumar D ^d   Ames, Bruce N ^c   Peden, David B ^d  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Tocopherol; Eosinophil; Inflammation; Mucous cell metaplasia; Ovalbumin; Ozone; Vitamin E

Indexed keywords

GAMMA TOCOPHEROL; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OVALBUMIN; OZONE; PEPTIDOLEUKOTRIENE;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; GENE EXPRESSION; INFLAMMATION; LUNG LAVAGE; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESPIRATORY TRACT ALLERGY; UPREGULATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; EOSINOPHILS; GAMMA-TOCOPHEROL; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-5; LEUKOTRIENES; MALE; OVALBUMIN; OZONE; RATS; RATS, INBRED BN; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY MUCOSA;

RATTUS; RATTUS NORVEGICUS;

EID: 34548487990     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.07.013     Document Type: Article

References (53)

1. Tolbert P.E., Mulholland J.A., MacIntosh D.L., Xu F., Daniels D., Devine O.J., et al. Air quality and pediatric emergency room visits for asthma in Atlanta, Georgia, USA. Am. J. Epidemiol. 151 (2000) 798-810
2. Gent J.F., Triche E.W., Holford T.R., Belanger K., Bracken M.B., Beckett W.S., et al. Association of low-level ozone and fine particles with respiratory symptoms in children with asthma. JAMA 290 (2003) 1859-1867
3. Lewis T.C., Robins T.G., Dvonch J.T., Keeler G.J., Yip F.Y., Mentz G.B., et al. Air pollution-associated changes in lung function among asthmatic children in Detroit. Environ. Health Perspect. 113 (2005) 1068-1075
4. Kehrl H.R., Peden D.B., Ball B., Folinsbee L.J., and Horstman D. Increased specific airway reactivity of persons with mild allergic asthma after 7.6 hours of exposure to 0.16 ppm ozone. J. Allergy Clin. Immunol. 104 (1999) 1198-1204
5. Peden D.B., Setzer Jr. R.W., and Devlin R.B. Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics. Am. J. Respir. Crit. Care Med. 151 (1995) 1336-1345
6. Peden D.B., Boehlecke B., Horstman D., and Devlin R. Prolonged acute exposure to 0.16 ppm ozone induces eosinophilic airway inflammation in asthmatic subjects with allergies. J. Allergy Clin. Immunol. 100 (1997) 802-808
7. Scannell C., Chen L., Aris R.M., Tager I., Christian D., Ferrando R., et al. Greater ozone-induced inflammatory responses in subjects with asthma. Am. J. Respir. Crit. Care Med. 154 (1996) 24-29
8. Balmes J.R., Aris R.M., Chen L.L., Scannell C., Tager I.B., Finkbeiner W., et al. Effects of ozone on normal and potentially sensitive human subjects. Part I. Airway inflammation and responsiveness to ozone in normal and asthmatic subjects. Res. Rep. Health Eff. Inst. (1997) 1-37 (discussion 81-99)
9. Kelly F.J., Mudway I., Blomberg A., Frew A., and Sandstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet 354 (1999) 482-483
10. Ochs-Balcom H.M., Grant B.J., Muti P., Sempos C.T., Freudenheim J.L., Browne R.W., et al. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD. Eur. J. Clin. Nutr. 60 (2006) 991-999
11. Kongerud J., Crissman K., Hatch G., and Alexis N. Ascorbic acid is decreased in induced sputum of mild asthmatics. Inhal. Toxicol. 15 (2003) 101-109
12. Mak J.C., Leung H.C., Ho S.P., Law B.K., Lam W.K., Tsang K.W., et al. Systemic oxidative and antioxidative status in Chinese patients with asthma. J. Allergy Clin. Immunol. 114 (2004) 260-264
13. Powell C.V., Nash A.A., Powers H.J., and Primhak R.A. Antioxidant status in asthma. Pediatr. Pulmonol. 18 (1994) 34-38
14. Ghosh S., Janocha A.J., Aronica M.A., Swaidani S., Comhair S.A., Xu W., et al. Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation. J. Immunol. 176 (2006) 5587-5597
15. Misso N.L., Brooks-Wildhaber J., Ray S., Vally H., and Thompson P.J. Plasma concentrations of dietary and nondietary antioxidants are low in severe asthma. Eur. Respir. J. 26 (2005) 257-264
16. Patel B.D., Welch A.A., Bingham S.A., Luben R.N., Day N.E., Khaw K.T., et al. Dietary antioxidants and asthma in adults. Thorax 61 (2006) 388-393
17. Troisi R.J., Willett W.C., Weiss S.T., Trichopoulos D., Rosner B., and Speizer F.E. A prospective study of diet and adult-onset asthma. Am. J. Respir. Crit. Care Med. 151 (1995) 1401-1408
18. de Luis D.A., Armentia A., Aller R., Asensio A., Sedano E., Izaola O., et al. Dietary intake in patients with asthma: a case control study. Nutrition 21 (2005) 320-324
19. Centanni S., Santus P., Di Marco F., Fumagalli F., Zarini S., and Sala A. The potential role of tocopherol in asthma and allergies: modification of the leukotriene pathway. BioDrugs 15 (2001) 81-86
20. Pearson P.J., Lewis S.A., Britton J., and Fogarty A. Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial. Thorax 59 (2004) 652-656
21. Suchankova J., Voprsalova M., Kottova M., Semecky V., and Visnovsky P. Effects of oral alpha-tocopherol on lung response in rat model of allergic asthma. Respirology 11 (2006) 414-421
22. Shahar E., Hassoun G., and Pollack S. Effect of vitamin E supplementation on the regular treatment of seasonal allergic rhinitis. Ann. Allergy Asthma Immun. 92 (2004) 654-658
23. Cooney R.V., Franke A.A., Harwood P.J., Hatch-Pigott V., Custer L.J., and Mordan L.J. Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc. Natl. Acad. Sci. USA 90 (1993) 1771-1775
24. Christen S., Woodall A.A., Shigenaga M.K., Southwell-Keely P.T., Duncan M.W., and Ames B.N. gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc. Natl. Acad. Sci. USA 94 (1997) 3217-3222
25. Jiang Q., Christen S., Shigenaga M.K., and Ames B.N. gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am. J. Clin. Nutr. 74 (2001) 714-722
26. Wolf G. gamma-Tocopherol: an efficient protector of lipids against nitric oxide-initiated peroxidative damage. Nutr. Rev. 55 (1997) 376-378
27. Wagner K.H., Kamal-Eldin A., and Elmadfa I. Gamma-tocopherol-an underestimated vitamin?. Ann. Nutr. Metab. 48 (2004) 169-188
28. Jiang Q., Elson-Schwab I., Courtemanche C., and Ames B.N. gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. USA 97 (2000) 11494-11499
29. Jiang Q., and Ames B.N. Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J. 17 (2003) 816-822
30. Hatch G.E., Slade R., Harris L.P., McDonnell W.F., Devlin R.B., Koren H.S., et al. Ozone dose and effect in humans and rats. A comparison using oxygen-18 labeling and bronchoalveolar lavage. Am. J. Respir. Crit. Care Med. 150 (1994) 676-683
31. Bieri J.G., and Evarts R.P. Gamma tocopherol: metabolism, biological activity and significance in human vitamin E nutrition. Am. J. Clin. Nutr. 27 (1974) 980-986
32. Weber C., Podda M., Rallis M., Thiele J.J., Traber M.G., and Packer L. Efficacy of topically applied tocopherols and tocotrienols in protection of murine skin from oxidative damage induced by UV-irradiation. Free Radic. Biol. Med. 22 (1997) 761-769
33. Wagner J.G., Hotchkiss J.A., and Harkema J.R. Effects of ozone and endotoxin coexposure on rat airway epithelium: potentiation of toxicant-induced alterations. Environ. Health Perspect. 109 Suppl. 4 (2001) 591-598
34. Wagner J.G., Hotchkiss J.A., and Harkema J.R. Enhancement of nasal inflammatory and epithelial responses after ozone and allergen coexposure in Brown Norway rats. Toxicol. Sci. 67 (2002) 284-294
35. Coffey M.J., Wheeler C.S., Gross K.B., Eschenbacher W.L., Sporn P.H., and Peters-Golden M. Increased 5-lipoxygenase metabolism in the lungs of human subjects exposed to ozone. Toxicology 114 (1996) 187-197
36. Shimizu T., Hirano H., Majima Y., and Sakakura Y. A mechanism of antigen-induced mucus production in nasal epithelium of sensitized rats. A comparison with lipopolysaccharide-induced mucus production. Am. J. Respir. Crit. Care Med. 161 (2000) 1648-1654
37. Vargaftig B.B., and Singer M. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am. J. Respir. Cell Mol. Biol. 28 (2003) 410-419
38. Longphre M., Zhang L.Y., Harkema J.R., and Kleeberger S.R. Mast cells contribute to O3-induced epithelial damage and proliferation in nasal and bronchial airways of mice. J. Appl. Physiol. 80 (1996) 1322-1330
39. Frischer T., Studnicka M., Halmerbauer G., Horak Jr. F., Gartner C., Tauber E., et al. Ambient ozone exposure is associated with eosinophil activation in healthy children. Clin. Exp. Allergy 31 (2001) 1213-1219
40. Fischer B.M., and Voynow J.A. Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am. J. Respir. Cell Mol. Biol. 26 (2002) 447-452
41. Shao M.X., and Nadel J.A. Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme. J. Immunol. 175 (2005) 4009-4016
42. Miyahara N., Miyahara S., Takeda K., and Gelfand E.W. Role of the LTB4/BLT1 pathway in allergen-induced airway hyperresponsiveness and inflammation. Allergol. Intern. 55 (2006) 91-97
43. Busse W., and Kraft M. Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest 127 (2005) 1312-1326
44. Jiang Q., Lykkesfeldt J., Shigenaga M.K., Shigeno E.T., Christen S., and Ames B.N. Gamma-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation. Free Radic. Biol. Med. 33 (2002) 1534-1542
45. Campbell S.E., Stone W.L., Whaley S.G., Qui M., and Krishnan K. Gamma (gamma) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (gamma) expression in SW 480 human colon cancer cell lines. BMC Cancer 3 (2003) 25
46. De Pascale M.C., Bassi A.M., Patrone V., Villacorta L., Azzi A., and Zingg J.M. Increased expression of transglutaminase-1 and PPARgamma after vitamin E treatment in human keratinocytes. Arch. Biochem. Biophys. 447 (2006) 97-106
47. Ueki S., Matsuwaki Y., Kayaba H., Oyamada H., Kanda A., Usami A., et al. Peroxisome proliferator-activated receptor gamma regulates eosinophil functions: a new therapeutic target for allergic airway inflammation. Int. Arch. Allergy Immunol. 134 Suppl. 1 (2004) 30-36
48. Lee S.Y., Kang E.J., Hur G.Y., Jung K.H., Jung H.C., Lee S.Y., et al. Peroxisome proliferator-activated receptor-gamma inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells. Am. J. Physiol.: Lung Cell. Mol. Physiol. 291 (2006) L84-L90
49. Romieu I., Meneses F., Ramirez M., Ruiz S., Perez Padilla R., Sienra J.J., et al. Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone. Am. J. Respir. Crit. Care Med. 158 (1998) 226-232
50. Romieu I., Sienra-Monge J.J., Ramirez-Aguilar M., Moreno-Macias H., Reyes-Ruiz N.I., Estela del Rio-Navarro B., et al. Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 59 (2004) 8-10
51. Samet J.M., Hatch G.E., Horstman D., Steck-Scott S., Arab L., Bromberg P.A., et al. Effect of antioxidant supplementation on ozone-induced lung injury in human subjects. Am. J. Respir. Crit. Care Med. 164 (2001) 819-825
52. Mudway I.S., Behndig A.F., Helleday R., Pourazar J., Frew A.J., Kelly F.J., et al. Vitamin supplementation does not protect against symptoms in ozone-responsive subjects. Free Radic. Biol. Med. 40 (2006) 1702-1712
53. Jang A.S., Choi I.S., Yang S.Y., Kim Y.G., Lee J.H., Park S.W., et al. Antioxidant responsiveness in BALB/c mice exposed to ozone. Respiration 72 (2005) 79-84